Form 4: Definitive Healthcare CEO's Routine Stock Disposition

Definitive Healthcare Corp. CEO Kevin Coop disposed of 175,524 shares of Class A Common Stock for tax withholding obligations related to RSU vesting.

Summary

• Kevin Coop, Chief Executive Officer and Director of Definitive Healthcare Corp. (DH), reported a disposition of company stock.
• The transaction involved 175,524 shares of Class A Common Stock.
• The shares were disposed of at a price of $1.28 per share.
• This disposition was made to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported Restricted Stock Units (RSUs).
• Following this transaction, Kevin Coop beneficially owns 5,116,465 shares of Class A Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary disposition of shares to cover tax liabilities associated with RSU vesting, rather than a discretionary sale indicating a change in management's outlook.

Negatives

• A reduction in direct beneficial ownership by a key executive, even for tax purposes, could be viewed as a slight decrease in direct insider alignment, though it is a non-discretionary transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that tax-related dispositions of shares upon RSU vesting are a standard and routine practice for executives in publicly traded companies across all industries. This transaction does not indicate any specific industry trend or competitive positioning.

Comparison to Industry Standards

• The mechanism of withholding shares for tax obligations upon RSU vesting is a common practice, consistent with compensation structures observed in technology and healthcare companies globally, such as Microsoft, Apple, and Pfizer, where equity compensation is a significant component of executive pay.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a signal of management's confidence or lack thereof.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Definitive Healthcare, DH, Kevin Coop, Form 4, Insider Transaction, Stock Disposition, RSU Vesting, Tax Withholding, Corporate Governance